[Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
Aubeny
E
E
Bureau
A
A
Gabeaud
P
P
Heard
I
I
Eucher
M
M
Husson
T
T
Meng
L
L
Riotte
S
S
D000019:Abortifacient Agents; D000023:Abortion Applicants; D000028:Abortion, Induced; D001695:Biology; D019049:Developed Countries; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction
D000019:Abortifacient Agents; D006727:Hormone Antagonists; D006728:Hormones; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D015735:Mifepristone
Abortifacient Agents; Abortion Seekers; Abortion, Drug Induced; Abortion, Induced; Biology; Developed Countries; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; France; Hormone Antagonists; Hormones; Mediterranean Countries; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins; Prostaglandins, Synthetic--administraction and dosage; Reproduction; Ru-486; Western Europe